Search Results - "Pu, Tianjie"

Refine Results
  1. 1

    MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1–cMET signaling by Yin, Lijuan, Li, Jingjing, Wang, Jing, Pu, Tianjie, Wei, Jing, Li, Qinlong, Wu, Boyang Jason

    Published in Oncogene (18-02-2021)
    “…Perineural invasion (PNI), a pathologic feature defined as cancer cell invasion in, around, and through nerves, is an indicator of poor prognosis and survival…”
    Get full text
    Journal Article
  2. 2

    MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness by Li, Jingjing, Pu, Tianjie, Yin, Lijuan, Li, Qinlong, Liao, Chun-Peng, Wu, Boyang Jason

    Published in Oncogene (16-04-2020)
    “…The tumor microenvironment plays a critical role in prostate cancer (PC) development and progression. Inappropriate activation of the stroma potentiates the…”
    Get full text
    Journal Article
  3. 3

    Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels by Yang, Libo, Lu, Dongli, Lai, Yutian, Shen, Mengjia, Yu, Qiuxiao, Lei, Ting, Pu, Tianjie, Bu, Hong

    Published in Annals of surgical oncology (01-02-2021)
    “…Background We aimed to analyze the effects of radiotherapy (RT) on the incidence rate of ipsilateral breast event (IBE) in ductal carcinoma in situ (DCIS)…”
    Get full text
    Journal Article
  4. 4

    Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP by Pu, Tianjie, Shen, Mengjia, Li, Shi, Yang, Libo, Gao, Hongwei, Xiao, Lin, Zhong, Xiaorong, Zheng, Hong, Liu, Yueping, Ye, Feng, Bu, Hong

    Published in Laboratory investigation (01-09-2019)
    “…Metastasis is an essential event for breast cancer (BC) progression even after initial surgery. The identification of patients with a high probability of…”
    Get full text
    Journal Article
  5. 5

    The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines by Yang, Libo, Chen, Min, Pu, Tianjie, Wu, Shuang, Wei, Bing, Yang, Jieliang, Bu, Hong, Zhang, Zhang

    Published in Journal of clinical pathology (01-05-2020)
    “…The aim of this study is to analyse differences in clinicopathologic features among reclassified human epidermal growth factor receptor-2 (HER2) fluorescence…”
    Get more information
    Journal Article
  6. 6

    High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor by Lei, Ting, Yin, Lijuan, Zhang, Hongying, Wei, Bing, Chen, Huijiao, Pu, Tianjie, Yang, Libo, Ye, Feng, Zhang, Zhang, Bu, Hong

    Published in International journal of clinical oncology (01-12-2020)
    “…Background microRNAs, which expound the transcriptional regulation of gene expression, have been validated as prognostic markers in many tumors. The…”
    Get full text
    Journal Article
  7. 7

    Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy by Yang, Libo, Zhong, Xiaorong, Pu, Tianjie, Qiu, Yan, Ye, Feng, Bu, Hong

    Published in World journal of surgical oncology (07-03-2018)
    “…Neoadjuvant chemotherapy (NAC) is widely used in advanced breast cancer patients. However, there is little known about conversion frequency of estrogen…”
    Get full text
    Journal Article
  8. 8

    WLS-Wnt signaling promotes neuroendocrine prostate cancer by Bland, Tyler, Wang, Jing, Yin, Lijuan, Pu, Tianjie, Li, Jingjing, Gao, Jin, Lin, Tzu-Ping, Gao, Allen C., Wu, Boyang Jason

    Published in iScience (22-01-2021)
    “…Neuroendocrine prostate cancer (NEPC) is a lethal prostate cancer subtype arising as a consequence of more potent androgen receptor (AR) targeting in…”
    Get full text
    Journal Article
  9. 9

    External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China by Pu, Tianjie, Shui, Ruohong, Shi, Jie, Liang, Zhiyong, Yang, Wentao, Bu, Hong, Li, Qin, Zhang, Zhang

    Published in BMC cancer (22-10-2019)
    “…An External Quality Assessment (EQA) program was developed to investigate the status of estrogen receptor (ER), progesterone receptor (PR), and Ki-67…”
    Get full text
    Journal Article
  10. 10

    Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p by Li, Shi, Pu, Tianjie, Xiao, Lin, Gao, Hongwei, Li, Li, Ye, Feng, Liu, Yueping, Bu, Hong

    Published in Journal of breast cancer (01-03-2019)
    “…Ductal carcinoma (DCIS) contributes to 20%-30% of newly diagnosed cases of breast cancer in China. Although the breast cancer-specific mortality of DCIS is…”
    Get full text
    Journal Article
  11. 11

    The expression of aldehyde dehydrogenase family in breast cancer by Qiu, Yan, Pu, Tianjie, Li, Li, Cheng, Fei, Lu, Changli, Sun, Linyong, Teng, Xiao, Ye, Feng, Bu, Hong

    Published in Journal of breast cancer (01-03-2014)
    “…It is widely accepted that aldehyde dehydrogenase (ALDH) activity is a signature of breast cancer stem cells, and high activity has been reported to be…”
    Get full text
    Journal Article
  12. 12

    Inhibition of CHRM1 reverts docetaxel resistance in castration‐resistant prostate cancer by Wang, Jing, Bland, Tyler, Wei, Jing, Pu, Tianjie, Lin, Tzu‐Ping, Wu, Boyang

    Published in The FASEB journal (01-05-2022)
    “…Background Chemotherapy remains the major treatment option for castration‐resistant prostate cancer (CRPC). Docetaxel (DTX)‐based chemotherapy provides…”
    Get full text
    Journal Article
  13. 13

    Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer by Wang, Jing, Li, Jingjing, Yin, Lijuan, Pu, Tianjie, Wei, Jing, Karthikeyan, Varsha, Lin, Tzu-Ping, Gao, Allen C., Wu, Boyang Jason

    Published in Oncogene (09-09-2022)
    “…Neuroendocrine prostate cancer (NEPC), a lethal subset of prostate cancer, is characterized by loss of AR signaling and resulting resistance to AR-targeted…”
    Get full text
    Journal Article
  14. 14

    Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses by Zhang, Yu, Luo, Xiulan, Chen, Min, Yang, Libo, Lei, Ting, Pu, Tianjie, Wei, Bing, Bu, Hong, Zhang, Zhang

    Published in Breast cancer research and treatment (01-07-2022)
    “…Purpose To compare the clinicopathologic features and prognosis of pleomorphic invasive lobular carcinoma (P-ILC) and classic ILC (C-ILC) according to the…”
    Get full text
    Journal Article
  15. 15

    Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer by Wei, Jing, Yin, Lijuan, Li, Jingjing, Wang, Jing, Pu, Tianjie, Duan, Peng, Lin, Tzu-Ping, Gao, Allen C, Wu, Boyang Jason

    Published in Cancer research (Chicago, Ill.) (15-08-2021)
    “…Androgen receptor (AR) is the primary oncogenic driver of prostate cancer, including aggressive castration-resistant prostate cancer (CRPC). The molecular…”
    Get full text
    Journal Article
  16. 16

    Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis by Chen, Min, Pu, Tianjie, Wei, Bing, Bu, Hong, Tang, Ping, Zhang, Zhang

    Published in Pathology, research and practice (01-03-2022)
    “…Secretory carcinoma of the breast (SCB) is a rare low-grade often triple-negative breast carcinoma. We aim to analyze the pathological and molecular features…”
    Get full text
    Journal Article
  17. 17

    Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast by Lei, Ting, Pu, Tianjie, Wei, Bing, Fan, Yingying, Yang, Libo, Shen, Mengjia, Chen, Min, Yang, Jieliang, Zhang, Yu, Zhang, Zhang, Bu, Hong

    Published in Journal of clinical pathology (01-01-2022)
    “…The aim of this study was to analyse the clinicopathological features and prognosis of human epidermal growth factor receptor-2 (HER2)-positive metaplastic…”
    Get more information
    Journal Article
  18. 18

    Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis by Deng, Ling, Lei, Qianqian, Wang, Yu, Wang, Zhu, Xie, Guiqin, Zhong, Xiaorong, Wang, Yanping, Chen, Nianyong, Qiu, Yan, Pu, Tianjie, Bu, Hong, Zheng, Hong

    Published in Oncotarget (12-12-2017)
    “…The purpose of this study was to identify microRNAs (miRNAs) closely associated with the prognosis of triple-negative breast cancer (TNBC) and their possible…”
    Get full text
    Journal Article
  19. 19

    Bidirectional Crosstalk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer by Wei, Jing, Yin, Lijuan, Li, Jingjing, Wang, Jing, Pu, Tianjie, Duan, Peng, Lin, Tzu-Ping, Gao, Allen C., Wu, Boyang Jason

    Published in Cancer research (Chicago, Ill.) (24-06-2021)
    “…Androgen receptor (AR) is the primary oncogenic driver of prostate cancer (PC), including aggressive castration-resistant prostate cancer (CRPC). The molecular…”
    Get full text
    Journal Article
  20. 20

    FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis by Chen, Shinan, Qiu, Yan, Guo, Peng, Pu, Tianjie, Feng, Ye, Bu, Hong

    Published in Oncology letters (01-06-2018)
    “…Human epidermal growth factor receptor 1 or 2 (HER1/2), and fibroblast growth factor receptor 1 (FGFR1) signaling serve critical roles in the progression of…”
    Get full text
    Journal Article